MACROH2A1 and colorectal carcinoma: Ex vivo analyses have demonstrated that the percentage of macroH2A1.1 transcript expression is significantly reduced in primary CRC tumors compared to normal tissues; moreover, bioinformatic approaches based on microarray datasets have proven useful in identifying the factors that regulate macroH2A1 splicing [86].